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DISC1 regulates N-methyl-D-aspartate
receptor dynamics: abnormalities induced
by a Disc1 mutation modelling a
translocation linked to major mental illness
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Paul Perry3, Matthew Pearson3, Costas Constantinides1, Hazel Davidson-Smith1, Mostafa Kabiri6, Barbara Duff7,
Mandy Johnstone 1,7, H. Greg Polites8, Stephen M. Lawrie 7, Douglas H. Blackwood 7, Colin A. Semple3,
Kathryn L. Evans1, Michel Didier9, Siddharthan Chandran5, Andrew M. McIntosh 7, David J. Price10, Miles D. Houslay11,
David J. Porteous 1 and J. Kirsty Millar1
Abstract
The neuromodulatory gene DISC1 is disrupted by a t(1;11) translocation that is highly penetrant for schizophrenia and
affective disorders, but how this translocation affects DISC1 function is incompletely understood. N-methyl-D-aspartate
receptors (NMDAR) play a central role in synaptic plasticity and cognition, and are implicated in the pathophysiology
of schizophrenia through genetic and functional studies. We show that the NMDAR subunit GluN2B complexes with
DISC1-associated trafficking factor TRAK1, while DISC1 interacts with the GluN1 subunit and regulates dendritic
NMDAR motility in cultured mouse neurons. Moreover, in the first mutant mouse that models DISC1 disruption by the
translocation, the pool of NMDAR transport vesicles and surface/synaptic NMDAR expression are increased. Since
NMDAR cell surface/synaptic expression is tightly regulated to ensure correct function, these changes in the mutant
mouse are likely to affect NMDAR signalling and synaptic plasticity. Consistent with these observations, RNASeq
analysis of the translocation carrier-derived human neurons indicates abnormalities of excitatory synapses and vesicle
dynamics. RNASeq analysis of the human neurons also identifies many differentially expressed genes previously
highlighted as putative schizophrenia and/or depression risk factors through large-scale genome-wide association and
copy number variant studies, indicating that the translocation triggers common disease pathways that are shared with
unrelated psychiatric patients. Altogether, our findings suggest that translocation-induced disease mechanisms are
likely to be relevant to mental illness in general, and that such disease mechanisms include altered NMDAR dynamics
and excitatory synapse function. This could contribute to the cognitive disorders displayed by translocation carriers.
Introduction
N-methyl-D-aspartate receptors (NMDAR) are vital for
synaptic plasticity and cognitive processes, and are strongly
implicated in the pathophysiology of schizophrenia in par-
ticular1. GRIN2A, encoding the NMDAR GluN2A subunit,
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was recently reported to show genome-wide significant
association with schizophrenia2, while genomic copy
number variants (CNVs) enriched in schizophrenia patients
target GRIN1, encoding the GluN1 subunit3,4. Such findings
support a role for NMDAR in psychiatric disorders, but
direct mechanistic insight is still required.
NMDAR function is regulated at many stages, including
subunit expression and composition, and dynamic mod-
ulation of surface and synaptic levels. The latter can be
elicited through control of NMDAR forward trafficking to
the plasma membrane, subsequent insertion into synap-
ses, or endocytosis5. The obligatory GluN1 subunit is
incorporated into all NMDAR, along with other subunit
types including GluN2A/B. GluN1 is synthesised in excess
and stored within the endoplasmic reticulum (ER), where
NMDAR are assembled prior to transportation to the
Golgi and onwards to the cell surface5. Every stage of
NMDAR forward trafficking is tightly modulated to
ensure that the required quantity of receptors is present at
the cell surface and synapse5. Genetic dysregulation of
forward trafficking would be predicted to adversely affect
the NMDAR function, with knock-on effects for synapse
strength and plasticity5.
DISC1 is disrupted in a large, multi-generation family
by a chromosomal t(1;11) translocation that is linked to
major mental illness6–8. DISC1 is critical for several
processes in the developing and adult brain9,10, and has
been connected to NMDAR function through regulation
of downstream processes that underlie synaptic plasti-
city11,12. DISC1 also regulates neuronal microtubule-
based cargo transport, including trafficking of mitochon-
dria, synaptic vesicles and messenger RNAs13–15, and
associates with the motor protein adaptors TRAK1 and
TRAK216,17.
Here we demonstrate direct interaction between GluN1
and DISC1, and association between GluN2B and TRAK1.
Applying a novel live-imaging method, we demonstrate
that DISC1 regulates dendritic NMDAR motility. Utilising
a mouse model of DISC1 disruption by the translocation,
we show that mutant mouse neurons exhibit increased
NMDAR fast active transport and cell surface/synaptic
NMDAR expression. These observations implicate dys-
regulated NMDAR dynamics/signalling and excitatory
synapse dysfunction in the psychiatric disorders displayed
by translocation carriers. In further support of a general
disease mechanism revealed by the translocation, we find
that it impacts the biological pathways highlighted by
independent schizophrenia and depression GWAS and
CNV studies.
Materials and methods
Detailed materials and methods for all experiments are
provided in the Supplementary information. Essential
information is included below.
Generation of induced pluripotent stem cells (IPSC) from
dermal fibroblasts
Dermal fibroblasts were reprogrammed using non-
integrating episomal plasmids incorporating Oct3/4,
shRNA to p53, SOX2, KLF4, L-MYC and LIN2818, and
converted to neural precursor cells by dual-SMAD sig-
nalling inhibition19.
Generation of a mouse model of the t(1;11) translocation
Mice were genetically engineered using Regeneron’s
GEMM platform (VelociMouse®). Disc1 was targeted in
embryonic stem cell clones using a vector containing
mouse Disc1 genomic DNA encompassing exons 6, 7 and
8 as the 5′ homologous arm, and sequences 3′ of Disc1 as
the 3′ homologous arm. Human chromosome 11 genomic
DNA, encompassing putative exons 4, 5, 6, 7a and 7b of
DISC1FP120 followed by a loxP-flanked neo cassette, was
inserted between the mouse homologous arms. Homo-
logous recombination removed 98,550 bp of mouse Disc1
downstream of exon 8 and inserted 114,843 bp of human
DISC1FP1 sequence. The edited endogenous mouse Disc1
locus mimics the DISC1/DISC1FP1 gene fusion event on
the derived chromosome 1 in translocation carriers, and
the mutation is referred to as Der1.
RNA sequencing
Three control and three translocation-carrying neural
precursor lines were each differentiated to neurons
independently in triplicate. RNA was extracted and
sequenced to a depth of 60 million paired-end reads.
Differential gene expression was analysed at the whole
gene and single exon levels using DESeq2 from the R
statistical package21 and DEXSeq22, respectively.
Dendra2 NMDAR trafficking assay
A Dendra2 tag was fused to the GluN1 C terminus.
Dendra2 exhibits green fluorescence, but can be photo-
converted to red fluorescence. DIV7 hippocampal neu-
rons were co-transfected with GluN1–Dendra2 plus
HA–GluN2B to maximise NMDAR assembly, and
therefore trafficking outwith the ER. Dendra2 was pho-
toconverted within a region of interest positioned on a
primary dendrite. Time-lapse images were captured every
15 s for 3 min, and red fluorescence bidirectional move-
ment along dendrites was quantified. Essentially, den-
drites were divided into 5-μm bins, and red fluorescence
intensity was quantified within each bin at each timepoint.
Finally, the fluorescence intensity within each bin was
normalised to dendritic area and fluorescence intensity in
bin zero at time zero.
Fluorescence peak average velocities were determined
individually for each neuron using the 10-μm and 15-μm
bins where the peak was clearly identifiable. Maximum
velocity estimates were determined individually for each
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neuron using the 25–40-μm bins, where the appearance
of the leading edge of the wave of red fluorescence could
be ascertained.
Results
Neural precursor cells (NPC) and neurons derived from t
(1;11) translocation carriers
Dermal fibroblasts from translocation carriers diag-
nosed with schizophrenia, recurrent major depression,
cyclothymia or recurrent major depression plus bipolar
disorder (not otherwise specified) and karyotypically
normal family members (Supplementary Figure 1) were
reprogrammed using non-integrating episomes18. NPC
lines were generated from the IPSC (Supplementary Fig-
ure 2a–c) as described previously19. All NPC lines exhibit
typical morphology and form rosettes in the culture, with
almost 100% of cells expressing the neural progenitor
marker NES (Supplementary Figure 2c). Each NPC line
consistently differentiates to produce neurons expressing
the neuronal marker βIII-tubulin (Supplementary Figure
2d).
To examine the effect of the translocation upon DISC1
transcript levels in the t(1;11) family NPCs and neurons,
NPCs were differentiated over 5 weeks, with sampling at
time zero (before differentiation onset) and weekly
thereafter, to obtain the RNA for quantitative RT-PCR
analysis. Wild-type DISC1 expression is decreased in
translocation-carrying NPCs and neurons relative to
controls (Fig. 1a). Moreover, DISC1 expression increases
as differentiation progresses (Fig. 1a, b), although the
proportional change in each week is not altered by the
translocation (Fig. 1b). DISC1 expression may therefore
be particularly important in neurons. An antibody that
detects full-length DISC1 (Supplementary Figure 3a)
confirmed its reduced expression in NPCs and neurons
(Fig. 1c, d).
Chimeric CP1 and CP60/69 transcripts, resulting from
translocation-induced DISC1 gene fusion to the
DISC1FP1 (otherwise known as Boymaw) gene on the
derived chromosome 120, were PCR-amplified from NPCs
and neurons derived from translocation carriers (Fig. 1e).
These transcripts encode aberrant forms of DISC1, which,
when exogenously expressed, are deleterious20, thus they
are likely damaging to the brain in vivo. However, their
endogenous expression awaits confirmation.
DISC2 and DISC1FP1, also disrupted by the transloca-
tion, are expressed in the NPCs and neurons, but at low,
non-quantifiable levels (Supplementary Figure 3b).
Transcriptomic analysis of t(1;11) family neurons
We next performed RNA sequencing (RNASeq) analy-
sis as an unbiased screen for the effects of the transloca-
tion upon gene expression in the human cortical neurons.
The translocation lines used were derived from patients
diagnosed with schizophrenia, recurrent major depression
or cyclothymia. The use of cross-diagnostic samples
aimed to ensure that the major effects of the translocation
are identified, rather than any disorder-specific effects due
to genetic background. Overall, 1,256 (BaseMean>10) of
22,753 expressed genes were found to be differentially
expressed (adjusted p < 0.05, Fig. 2a, Supplementary Table
1a). A total of 938 genes also exhibit differential expres-
sion of individual exons (adjusted p < 0.05), an indicator of
altered isoform expression (Supplementary Table 1b).
IPSC-derived neuron cultures are a mix of cell types,
thus it is possible that the translocation could affect gene
expression patterns via influences upon cell fate. How-
ever, analysis of genes whose expressions were deter-
mined to be enriched in mouse or human astrocytes and
neurons by enriched cell or single-cell RNASeq analy-
sis20,21 found that only 7/41 mouse and 3/21 human
astrocyte markers, and 8/25 mouse and 5/34 human
neuron markers are dysregulated (Supplementary Table
1c, d). Four of the dysregulated mouse neuron markers,
DLX1, DLX2, DLX5 and DLX6, are already known to be
regulated by DISC1, indicating a subtle shift in neuronal
properties22,23. Classic markers of neurons, and of inhi-
bitory GABAergic neurons, are also unaffected (Supple-
mentary Table 1d). Moreover, analysis of genes whose
expressions are enriched in specific ‘communities’ of
human excitatory and inhibitory neurons21 found little
indication of change to either type overall (Supplementary
Table 1e). Thus, the translocation does not affect the
proportion of astrocytes versus neurons, or of excitatory
versus inhibitory neurons, although neuron properties
may be subtly altered. This is consistent with a previous
study which examined the effects of a DISC1 mutation
upon gene expression in IPSC-derived neurons22.
A total of 300 and 71 of the dysregulated genes,
respectively, are also differentially expressed in IPSC-
derived neurons carrying a frameshift mutation in DISC1
exon 1223 (hypergeometric probability p= 2.5E-21 Sup-
plementary Table 1a, b) or exon 822 (p= 0.00002), indi-
cating that independent DISC1 mutations have
overlapping effects. Differential DISC1 expression was not
initially detected in the whole-gene analysis, presumably
due to the presence of chimeric DISC1 transcripts origi-
nating from both derived chromosomes (Fig. 1e, Supple-
mentary Figure 3c). However, comparison of reads that
span intron 8, the location of the translocation breakpoint
and that can therefore only arise from wild-type tran-
scripts, indicates that wild-type DISC1 transcripts are
indeed reduced (Fig. 2b).
Due to the potential for positional, or other, effects of
the translocation upon neighbouring gene expression, we
examined the transcript levels over a region of approxi-
mately 20Mb proximal and distal to the translocation
breakpoints on chromosomes 1 and 11. Such analysis
Malavasi et al. Translational Psychiatry  (2018) 8:184 Page 3 of 16
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identified a number of differentially expressed genes and
exons, and possible clustering of dysregulated genes
around the chromosome 11 breakpoint (Supplementary
Table 1f, g).
Gene ontology (GO) analysis (Fig. 2c) highlighted cell/
neuron projections (seven of the top 20 GO Component
terms), the post-synaptic density of excitatory synapses
(2/20) and vesicles/organelles (4/20). Additional sig-
nificant GO Process and GO Function terms relate to
synapse assembly, cell adhesion and the actin cytoskele-
ton. Ingenuity pathway analysis (IPA), a complementary
method, identified similar terms, including terms pre-
dicting that the translocation will affect synapse assembly
and function in mature neurons of the brain (Fig. 2d). IPA
also found that the term ‘movement of organelle’ was
significant (Fig. 2d). Given that the RNAseq analysis is
unbiased, it is notable that DISC1 regulates processes
related to at least three of the major enriched categories;
neurite extension;10 synaptic vesicle and mitochondrial
trafficking13,14 and actin remodelling11. We therefore infer
that these process-related gene expression changes are
most likely due to DISC1 disruption.
While the translocation is unique to a single family,
translocation carriers do not present unusual clinical
symptoms outside the current diagnostic criteria, thus the
consequences of the translocation may converge upon
biological processes shared with other unrelated patients.
In support of this, several of the differentially expressed
genes in t(1;11) neurons correspond to genome-wide
association study (GWAS) findings for schizophrenia2,24.
Expression of 33 of the 348 genes from 25 of the 108
associated loci (hypergeometric probability p= 7E-6
indicates enrichment for loci containing at least one
dysregulated gene) identified in the first study, and 37 of
the 481 genes from 24 of the 145 loci (hypergeometric
probability p= 0.001) identified in the second study is
altered at the whole-gene and/or exon level in control
versus translocation lines (Supplementary Table 1a, b). Of
these dysregulated putative schizophrenia genes, changed
expressions of DRD2, encoding the dopamine D2
receptor, a target of all antipsychotics in clinical use, and
PDE4B, encoding a cAMP-degrading phosphodiesterase
and known DISC1 interactor25, were confirmed by
quantitative RT-PCR (Fig. 2e). Altered expression was
also confirmed for genes encoding the historical candidate
NRG126 and its receptor ERBB4 (Fig. 2e), both of which
have previously been linked functionally to DISC127,28.
Expression of 12 of 52 genes encoding synaptic proteins
that are targeted by recurrent CNVs in schizophrenia3 is
also altered (hypergeometric probability p= 0.001, Sup-
plementary Table 1a, b). Four of 70 genes at four of 44
depression-associated loci (9.1% of loci, no enrichment)29
identified through GWAS are also dysregulated (Supple-
mentary Table 1a, b).
Finally, three of four recently identified putative modi-
fier loci in the t(1;11) family30 are adjacent to the trans-
location breakpoints on chromosomes 1 or 11
(Supplementary Table 1f, g). Of the three genes of interest
identified therein, GRM5 is not dysregulated in the
human cortical neurons (Fig. 2e, Supplementary Table 1a,
b), CAPN8 is expressed at very low, non-quantifiable
levels and CNTN5 is dysregulated according to the
RNASeq analysis (p = 0.0008, Supplementary Table 1a,
b). However, although quantitative RT-PCR also suggests
increased CNTN5 expression, this did not achieve statis-
tical significance (Fig. 2e). The fourth locus, encompassing
PDE4D, could not be examined because the cell lines used
for RNASeq analysis and quantitative RT-PCR do not
carry the required haplotype.
A mutant mouse recapitulates the effect of the t(1;11)
translocation upon DISC1
A mutant mouse was generated by deleting genomic
DNA containing Disc1 exons 9–13 and replacing it with
human chromosome 11 genomic DNA containing rele-
vant DISC1FP1 exons (Fig. 1f). This mimics the gene
fusion caused by the translocation on the derived chro-
mosome 120, thus we refer to the mutation as Der1.
Quantitative RT-PCR demonstrated that wild-type
Disc1 transcript expression is reduced by approximately
(see figure on previous page)
Fig. 1 DISC1 expression in neural precursors and neurons derived from members of the t(1;11) family by the IPSC route, and in the Der1
mouse model. a Quantitative RT-PCR analysis of DISC1 transcripts in NPCs and differentiating neurons over 5 weeks. Data analysed by two-tailed t
test (NPC samples only) and one-way ANOVA (all samples, p < 0.0001), with pairwise Bonferroni post-test. b Data from a expressed as percentage of
the control. Data analysed by one-way ANOVA (p < 0.0001) with pairwise Bonferroni post-test between NPC and each week of differentiation.
Numbers above the columns indicate fold-change in comparison to the previous week. c and d Immunoblotting of DISC1 protein in neural
precursors, (c), or NPCs differentiated to neurons in triplicate (d). Left, representative immunoblots; right, densitometric analysis. Data analysed by
two-tailed t test. e Detection of chimeric CP60/CP69 and CP1 transcripts by RT-PCR and sequencing. f Schematic of the mouse endogenous Disc1
allele targeting strategy. g Quantitative RT-PCR analysis of Disc1 transcripts in adult mouse whole brain. Data analysed by two-tailed t test. h Disc1
protein expression in adult mouse whole brain. Left, representative immunoblot; right, quantification. Data analysed by two-tailed t test. ns, non-
specific bands. i Detection of chimeric CP60/CP69 transcripts by RT-PCR and sequencing. NTC non-template control, C control, T translocation carrier,
WT Disc1wt/wt; HET, Disc1wt/Der1; HOM and Disc1Der1/Der1. Error bars represent SEM; *p < 0.05; **p < 0.01 and ***p < 0.001; n indicated on graphs
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half in whole brain isolated from adult heterozygous Der1
(Disc1wt/Der1) mice in comparison with wild-type (Disc1wt/
wt) mice (Fig. 1g). Full-length Disc1 protein expression is
detected at ~100 kDa, and is correspondingly reduced in
Disc1wt/Der1 versus Disc1wt/wt mice (Fig. 1h). As expected,
wild-type Disc1 transcripts and protein were undetectable
in whole brain from homozygous (Disc1Der1/Der1) mice
(data not shown, Fig. 1h). CP60/69 transcripts were
detected using RT-PCR in whole brain from adult Disc1wt/
Der1 and Disc1Der1/Der1 mice (Fig. 1i), and quantitative RT-
PCR in Disc1Der1/Der1 mice demonstrated widespread
expression of these transcripts (Supplementary Figure 3d).
Quantitative analysis of wild-type Disc1 expression in
Disc1wt/wt mice generated a similar pattern of expression
to that of the chimeric transcripts (Supplementary Figure
3d), indicating that Disc1 promoter activity is not greatly
affected by the Der1 mutation. Further characterisation of
the Der1 mutant mouse will be published elsewhere.
Interaction between DISC1 and GluN1
Immunoprecipitation experiments using endogenous
brain proteins have previously demonstrated that GluN1
and Disc1 exist in shared complexes in vivo31. Here, using
FLAG-DISC1 and HA-tagged GluN1, we confirmed that
they can be co-immunoprecipitated using COS7 cells (Fig.
3a). We next used FLAG-DISC1 to probe peptide arrays of
the GluN1 cytoplasmic tail, encompassing the alternatively
spliced C0, C1 and C2 cassettes (Fig. 3b)32. FLAG-DISC1
was found to bind directly to GluN1 peptide spots 1–16,
encompassing amino acids 831–930 and, most strongly, to
three regions, within peptides 6–8, 13 and 16, corre-
sponding to the C1, C2 and C0 cassettes. To confirm DISC1
binding to these regions, we demonstrated that FLAG-
DISC1 efficiently co-immunoprecipitates GST-tagged
GluN1 C0-C1-C2 from COS7 cell lysates (Fig. 3c). All
known GluN1 isoforms contain at least one of these cas-
settes32 and thus can potentially interact with DISC1.
Reciprocal probing of a human DISC1 peptide array
with the cytoplasmic tail of GluN1 fused to FLAG
revealed a GluN1 contact site between amino acids
361–385 (Fig. 3d). To confirm this, an alanine scanning
peptide array of DISC1 amino acids 361–385 was inter-
rogated with the same GluN1 probe (Fig. 3e), revealing
that binding to the wild-type sequence is substantially
weakened by alanine conversion of any one of the amino
acids E374, L380, E381, D382, L383, E384 and Q385. The
DISC1 head domain therefore contacts GluN1 via a single
site in which residues 380–385 are critical for binding.
This binding site was independently confirmed by co-
immunoprecipitating HA–GluN1 and GST-DISC1 amino
acids 358–499 from COS7 cells (Fig. 3f). Moreover, exo-
genous DISC1 co-localises with endogenous GluN1 in
cultured DIV8 and DIV14 hippocampal neurons (Fig. 3g).
These observations indicate that DISC1 and the putative
schizophrenia risk factor GluN13 have the capacity to
interact directly in vivo.
TRAK1 complexes with GluN2B
Because DISC1 interacts with GluN1 and regulates
cargo transport, we speculated that DISC1 and TRAK1
might be involved in NMDAR trafficking. To test this, we
co-transfected COS7 cells with TRAK1 plus NMDAR
subunit, GluN1 or GluN2B expression constructs. In the
absence of TRAK1, both GluN1 and HA–GluN2B pre-
dominantly co-localise with the ER marker Calreticulin
(Fig. 3h), while FLAG-TRAK1 is strongly targeted to the
mitochondria, as expected17 (Fig. 3i). In co-transfected
cells, there is no appreciable co-localisation between
FLAG-TRAK1 and GluN1 (Fig. 3i), but in the presence of
FLAG-TRAK1, HA–GluN2B redistributes from the ER to
the mitochondria (Fig. 3i). Moreover, in triple-transfected
cells, in the presence of HA–GluN2B plus FLAG-TRAK1,
a substantial proportion of GluN1 localises in the mito-
chondria (Fig. 3j), indicating that assembled NMDAR can
associate with TRAK1. We next immunoprecipitated
Trak1 from mouse brain synaptosome and light mem-
brane fractions, where both proteins are enriched33 (data
not shown), and demonstrated co-precipitation of
GluN2B (Fig. 3k, Supplementary Figure 4). The DISC1-
associated trafficking factor Trak1 thus associates with the
NMDAR GluN2B subunit in vivo.
DISC1, with TRAK1, is now well established as a reg-
ulator of neuronal intracellular trafficking34. The GluN1/
DISC1/TRAK1 and TRAK1/GluN2B associations there-
fore imply that DISC1 regulates the motility of GluN2B-
containing NMDAR.
(see figure on previous page)
Fig. 2 RNAseq analysis of human neurons. a Heatmap of differentially expressed genes (DESeq2, adjusted p < 0.05) in neurons from three control
(28, 29, 30, Supplementary Figure 1) and three translocation lines (18, schizophrenia; 24, recurrent major depression and 55, cyclothymia,
Supplementary Figure 1), three differentiations each. b Normalised RNASeq reads spanning DISC1 exons 8 and 9 in all samples used for RNASeq
analysis. c Top 20 significantly enriched GO component (top), top 15 GO process (middle) plus all GO function (bottom) terms for combined DESeq2
plus DEXSeq lists, indicating FDR-corrected q-values. Colours indicate related GO terms. d Gene networks relating to synapses and organelle
movement derived using DESeq2 plus DEXSeq lists in IPA. *Genes identified by DEXSeq; **genes identified by DEXSeq plus DESeq2; red, upregulated;
green, downregulated. e Quantitative RT-PCR confirms differential expression of DRD2, PDE4B, NRG1 and ERBB4, but not of CNTN5 and GRM5, using
three control and three translocation lines differentiated to neurons in triplicate. Data analysed by one-tailed t test. C control, T translocation carrier.
Error bars represent SEM; n indicated on graphs
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DISC1 dysregulates dendritic GluN1–Dendra2 motility in
mouse hippocampal neurons
To examine NMDAR motility in neurons, we fused the
green fluorescent protein Dendra2 to GluN1, which is
incorporated into all NMDAR. Dendritic
GluN1–Dendra2 has a granular appearance similar to that
of endogenous GluN1 (Fig. 4a, Supplementary Figure
5a)35. Dendra2 can be stably photoconverted to red
fluorescence, enabling tracking of a specific red GluN1
population (Supplementary Video). Dendra2 fusion to the
GluN1 C terminus does not interfere with the receptor
assembly or trafficking to synapses because
GluN1–Dendra2 co-localises with the post-synaptic
density marker PSD95 within dendritic spines (Supple-
mentary Figure 5b). This can only occur following proper
receptor assembly5.
Bulk GluN1–Dendra2 movement was quantified in
cultured wild-type hippocampal neurons expressing exo-
genous human DISC1 at days in vitro 8 (DIV8), an age at
which the dendritic arbour is suitably developed, but not
too complex. Following GluN1–Dendra2 photoconver-
sion, red fluorescence bidirectional spreading was imaged
and analysed every 15 s for a total of 2 min in successive 5-
μm bins along the dendrites (Supplementary Figure 5c-n).
We examined the effects of wild-type DISC1 and a
change of arginine to tryptophan at position 37 (37W) in
DISC1 (Supplementary Figures 6a–f, 7a, b). This sequence
variant has been reported in four individuals, all with a
diagnosis of psychiatric illness36,37, and dysregulates
DISC1/TRAK1 association17. Wild-type DISC1 over-
expression increases distal-moving red fluorescence in the
20−35-μm bins (Supplementary Figure 6c, d), while in the
proximal direction, it reduces red fluorescence intensity in
all bins (Supplementary Figure 7a, b). In contrast,
DISC1–37W overexpression increases and decreases
distal-moving red fluorescence in the 5−15-μm and 25
−35-μm bins, respectively (Supplementary Figure 6c, d),
while proximal-moving red fluorescence increases in the
5–20-μm bins (Supplementary Figure 7a, b).
These data are consistent with the existence of at least
two classes of distal-moving dendritic GluN1–Dendra2 in
young hippocampal neurons that are differentially influ-
enced by DISC1: (1) a slow-moving population in the
5–15/20-μm bins (average velocity = 0.2 μm/s in empty
vector-transfected neurons, Supplementary Figures 6d, e,
7b), representing the majority of the GluN1–Dendra2 and
(2) a fast-moving population in the 25–35-μm bins
(average velocity = 0.82 μm/s in empty vector-transfected
neurons, Supplementary Figures 6d, f, 7b).
These populations represent the trailing edge plus ‘crest’
and the leading edge, respectively, of a wave of motile
GluN1–Dendra2 (Supplementary Figures 6d, 7b). Our
evidence for these populations aligns well with estimates
of 0.2–0.3μm/s for the movement of dendritic ER vesi-
cles38 and with estimates of 0.76 μm/s for the motility rate
of assembled NMDAR-containing vesicles undergoing
fast active transport in dendrites39, thus the slow and fast
populations likely represent the ER GluN1 pool and
NMDAR-containing vesicles undergoing active transport,
respectively.
Altered dendritic NMDAR motility in Der1 mouse
hippocampal neurons
We next quantified bulk GluN1–Dendra2 movement
within neuronal dendrites from Disc1wt/wt and Disc1Der1/
Der1 mice using the same method (Fig. 4b–g, Supple-
mentary Figure 7c, d). The same two pools of GluN1 were
detected, with the distal-moving ER and transport vesicle
pools, respectively, decreased and increased in Disc1Der1/
Der1 mutant neurons (Fig. 4d, e). A similar, but less
marked, pattern of proximal GluN1–Dendra2 motility
was observed (Supplementary Figure 7c, d).
Altered dendritic NMDAR surface distribution in Der1
mouse hippocampal neurons
The NMDAR trafficking data indicate that DISC1
modulates NMDAR motility and consequently predict
dysregulated cell surface NMDAR expression in neurons
(see figure on previous page)
Fig. 3 DISC1 interacts with GluN1 and TRAK1 associates with GluN2B. a HA–GluN1 co-immunoprecipitates FLAG-DISC1 from transfected COS7
cells. b GluN1 cytoplasmic tail (C0-C1-C2) peptide array hybridised with Flag-DISC1. Each spot represents a single peptide. Red, black and green texts
mark the C0, C1 and C2 cassettes, respectively. ER retention signals are in bold. c FLAG-DISC1 co-immunoprecipitates GST-tagged C0-C1-C2. d DISC1
peptide array probed with FLAG-C0-C1-C2. e DISC1 361–385 GluN1 binding region alanine scan probed with FLAG-C0-C1-C2. C, unmutated peptide.
f HA–GluN1 co-immunoprecipitates GST-DISC1 amino acids 358–499 from transfected COS7 cells. g Co-localisation of FLAG-DISC1 and endogenous
GluN1 in cultured DIV8 and DIV14 hippocampal neurons. Arrowheads and arrows indicate example sites of co-localisation. h COS7 cells transfected
with GluN1 or HA–GluN2B expression constructs were labelled with antibodies specific for GluN1 or HA, plus the ER marker Calreticulin. i COS7 cells
co-transfected with FLAG-TRAK1 plus GluN1 (left) or HA–GluN2B (right) expression constructs were labelled using antibodies specific for GluN1 or HA,
plus anti-FLAG and the mitochondrial dye Mitotracker CMXRos. j COS7 cells triple transfected with FLAG-TRAK1, GluN1 plus HA–GluN2B expression
constructs were labelled using antibodies specific for GluN1, HA and FLAG, plus Mitotracker CMXRos. COS7 cells were used because they are ideal for
exogenous protein expression due to their high transfection efficiency, large size and low profile, which facilitate co-immunoprecipitation and co-
localisation studies to complement endogenous protein studies in neurons. k Trak1 immunoprecipitates GluN2B from adult mouse brain
synaptosome and light membrane fractions. Scale bars, 50 μm in G, otherwise 20 μm; white boxes indicate enlarged areas
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cultured from the Der1 mutant mouse. To test this, we
quantified the NMDAR cell surface expression in DIV21
cultured Disc1wt/wt, Disc1wt/Der1 and Disc1Der1/Der1 hip-
pocampal neurons, an age at which neurons have matured
and developed synapses. Cell surface expression of the
NMDAR subunits GluN1, GluN2A and GluN2B and of
the post-synaptic density marker PSD95 and βIII-tubulin
(Tuj1) was imaged at high resolution by three-
dimensional structured illumination microscopy (3D-
SIM, Supplementary Figure 8a), which achieved a lateral
image resolution of 180 nm for the NMDAR subunits and
120 nm for PSD95.
3D reconstructions of βIII-tubulin and GluN1, GluN2A
and GluN2B were used to estimate dendritic volume and
the number and volume of individual surface puncta of
each NMDAR subunit, respectively (Fig. 5a, b, Supple-
mentary Table 2). This analysis demonstrated increased
density of GluN1 and GluN2B puncta in Disc1wt/Der1 and
Disc1Der1/Der1 mutant neurons, while GluN2A puncta
density is increased only in Disc1Der1/Der1 mutant neurons.
Total surface expression is correspondingly increased in
Disc1wt/Der1 and Disc1Der1/Der1 mutant neurons. Average
puncta volumes are increased for all three NMDAR
subunits, but only in Disc1wt/Der1 neurons, suggesting that
NMDAR form larger clusters on the cell surface in het-
erozygous neurons. This observation supports the exis-
tence of putative aberrant proteins encoded by the
chimeric CP60/69 transcripts. These proteins retain a
region that is sufficient for self-association40, so there is
potential for dominant-negative effects due to the for-
mation of multimers consisting of wild-type and mutant
protein, a situation that occurs only in heterozygous cells.
At the neuronal cell surface NMDAR are present at
synaptic, perisynaptic and extrasynaptic sites5, thus only a
proportion of receptors co-localise with PSD95 at
synapses. Applying Pearson’s co-localisation coefficient,
which quantifies the overall correlation between two
fluorescent signals, indicates that PSD95 co-localisation
with GluN1 is substantially increased in Disc1Der1/Der1
mutant neurons (Fig. 5c, d). However, synaptic localisa-
tion of GluN2A and GluN2B is not greatly altered
(Supplementary Figure 9a, b). Since GluN1 subunits
cannot be transported to synapses unless they have
assembled with other subunit types, we suggest that this
discrepancy is related to the presence of two
GluN1 subunits in every NMDAR, with variable inclusion
of other subunit types, resulting in a clear effect for the
former, but not for the latter. If correct, the GluN1/PSD95
co-localisation data indicate that NMDAR are more
abundant at synapses in the Disc1Der1/Der1 mutant
neurons.
Hippocampus protein extract immunoblotting demon-
strated that total expression of GluN1, GluN2A and
GluN2B is unaltered by mutation in adult Disc1wt/Der1 or
Disc1Der1/Der1 mice (Supplementary Figure 9c), confirm-
ing that surface expression changes are due to altered
NMDA receptor subunit distribution.
Altered distribution of PSD95 in Der1 mouse hippocampal
neurons
PSD95 is one of the most abundant molecular scaffolds
at the post-synaptic density of excitatory synapses. It has
many functions including organisation of the post-
synaptic density, NMDAR stabilisation at synapses,
assembly of NMDAR-associated signalling complexes and
recruitment of AMPA receptors (AMPAR), the major
excitatory receptors in the brain41. PSD95 is thus a major
determinant of excitatory synapse function and neuro-
transmission. Expression of PSD95 was therefore quanti-
fied in the imaged set of hippocampal neurons to
determine whether synapse size and structure is also
affected by Der1 mutation.
Super-resolution microscopy has demonstrated the
existence of varying numbers of PSD95 puncta (nanodo-
mains) at the post-synaptic density42–44. Most synapses
have a single PSD95 nanodomain, but some have multi-
ples42–44. Using 3D-SIM, PSD95 is visible as a combina-
tion of single spots and distinct clusters of multiple
puncta (Fig. 6a, Supplementary Figure 8), indicating that
this super-resolution technique is able to resolve PSD95
nanodomains within clusters at the post-synaptic density.
Total dendritic PSD95 volume is not affected by the Der1
(see figure on previous page)
Fig. 4 Altered distal dendritic NMDAR trafficking in Disc1Der1/Der1 hippocampal neurons. a Green Dendra2 fluorescence in dendrites of a DIV8
mouse hippocampal neuron transfected with GluN1–Dendra2 plus HA–GluN2B. Scale bar, 5 μm. b and c Mean red fluorescence intensity (b), or ROI
dendritic length (c), in the central bin in Disc1wt/wt and Disc1Der1/Der1 DIV8 neurons was equal at time zero following photoconversion. d Quantification
of fluorescence intensity over time in successive 5 μm dendritic bins distal to the centre of the photoconversion ROI. Data analysed by timepoint-
paired two-tailed t test. e Model of dendritic GluN1–Dendra2 motility. Photoconverted GluN1–Dendra2 progresses in a wave-like fashion, with the
fastest and slowest moving GluN1–Dendra2 at the leading and trailing edges, respectively, and the bulk travelling as the ‘crest’. f Fluorescence peak
velocity estimates for the 10-μm and 15-μm bins. Average time to peak fluorescence was converted to velocity, indicated above each bar. Average
velocities were determined from the two bins. g Fast-moving GluN1–Dendra2 maximum velocity estimates for the 25-μm–40-μm bins. Average time
to fluorescence appearance was converted to velocity, indicated above each bar. Average velocities were determined from the four bins. WT, Disc1wt/
wt; HOM, Disc1Der1/Der1. Error bars represent SEM. ****p < 0.0001; ***p < 0.001; **p < 0.01; *p < 0.05; n indicated on graphs
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mutation (Fig. 6b), however its distribution is altered.
Analysis of the number of nanodomains per cluster
(Supplementary Figure 8b–f) found that Disc1wt/Der1 and
Disc1Der1/Der1 neurons have an increased density of single
nanodomains (Fig. 6c), and of small nanodomain clusters
of 2–3 (Fig. 6d).
Discussion
Recent large-scale GWAS and CNV studies implicate
excitatory synapses, NMDAR subunits GluN1 and
GluN2A, and synaptic plasticity as causal factors in
schizophrenia2–4,24. We show here that multiple genes
identified in these studies are differentially expressed in
human neurons carrying a t(1;11) linked to major mental
illness. Moreover, the gene DISC1, disrupted by the t
(1;11), encodes a direct interactor of the NMDAR obli-
gatory GluN1 subunit. This convergence of the t(1;11)
with schizophrenia risk genes indicates that the t(1;11) is a
trigger for disease pathways, which is shared with unre-
lated schizophrenia patients. Affective disorders are also
prevalent in t(1;11) carriers, and we found differential
expression of putative depression risk factors in the t
(1;11)-carrying human neurons, although not as strikingly
as for schizophrenia.
We demonstrate that DISC1 regulates NMDAR motility
within dendrites, a process that is critical for controlling
cell surface and synaptic NMDAR expression. NMDAR
motility is influenced by a DISC1–37W mutation36,37,
previously shown to affect mitochondrial motility17, and
by the mouse Der1 mutation which accurately models the
effect of the t(1;11) upon DISC1 expression. DISC1,
DISC1–37W and the Der1 mutation influence the size of
the GluN1 ER pool, indicating, in the absence of altered
NMDAR subunit expression, that DISC1 regulates the
NMDAR ER-exit. Indeed DISC1 is ER-associated16, and
may directly impact NMDAR ER-exit because the binding
site for DISC1 on GluN1 encompasses two ER retention
signals (Fig. 3b)5. However, a simple model whereby
increased/decreased ER-exit leads to, respectively,
decreased/increased transport pool size cannot fully
explain the effects of DISC1 upon NMDAR motility due
to the lack of an overt relationship between the observed
sizes of the ER and active transport pools. We therefore
propose that DISC1 influences the active transport pool
independently of ER-exit via TRAK1, which associates
with the NMDAR subunit GluN2B, and its role as a
regulator of neuronal cargo trafficking34.
Mouse neurons expressing DISC1–37W exhibit a
decreased pool of NMDAR undergoing fast active trans-
port, while Der1 mutant mouse neurons exhibit an
increased pool. Since the 37W variant has to date been
found only in psychiatric patients, this suggests that
dysregulation of this pool, up or down, is deleterious.
Upregulation of the pool in Der1 mutant mouse neurons
correlates strikingly with the augmented density and
overall volume of cell surface NMDAR clusters, suggest-
ing that increased trafficking/membrane insertion largely
account for the greater surface NMDAR volume.
NMDAR are constantly exchanged between synaptic and
extrasynaptic sites45, with synaptic insertion events
believed to result from stochastic post-synaptic density-
mediated capture of receptors undergoing lateral diffusion
within the cell membrane46. Consequently, the elevated
NMDAR surface volume in Der1 mutant mouse neurons
likely increases the probability of their diffusion to, and
insertion into, synapses, thus explaining the increased
synaptic localisation of GluN1.
In addition to the NMDAR abnormalities, the post-
synaptic density scaffold PSD95 is aberrantly distributed
in Der1 mutant mouse neurons. Post-synaptic density size
at excitatory synapses is directly related to the number of
PSD95 nanodomains present43 and to AMPAR expression
and synapse size/strength41. Moreover, the number of
PSD95 nanodomains at a synapse is proposed to be
directly related to the number of AMPAR at a
synapse42,44,47. Synaptic PSD95 nanodomain number
therefore likely predicts the synaptic AMPAR expression
and in turn, synapse strength, which is determined by the
(see figure on previous page)
Fig. 5 Altered dendritic NMDAR surface expression and GluN1 localisation to the post-synaptic density in Disc1wt/Der1 and Disc1Der1/Der1
hippocampal neurons. a Objects in 3D-SIM images were visualised using the Imaris Isosurface tool. Touching objects are separated with boundary
lines between touching objects visible in the enlarged images. Scale bars, 2 μm in the full-size images, 0.6 μm in enlarged insets indicated by white
boxes (b) GluN1, GluN2A or GluN2B surface puncta density, total surface volume and individual surface puncta volume (all normalised to dendritic
segment volume) from 3D reconstructions of primary dendrite segments of cultured DIV21 hippocampal neurons. Data analysed by Kruskal–Wallis
(puncta density p= 0.02, p= 0.03, p= 0.0004, total volume p= 0.0025, p= 0.4, p= 0.003, puncta volume p= 0.003, p < 0.0001, p < 0.0001 for GluN1,
GluN2A and GluN2B respectively) followed by Dunn’s multiple comparison test. c Reconstructed 3D-SIM images of dendrites. Co-localised voxels,
which contain signals from both PSD95 and surface-expressed GluN1 are shown in white. Scale bars, 3 μm. d GluN1 co-localisation with the PSD95
was evaluated on three measures. Pearson’s and Mander’s coefficients, respectively, indicate the overall correlation of each signal or amount of
GluN1 signal co-localised with PSD95 signal, and vice versa. Data were analysed by Kruskal–Wallis (p= 0.004, p= 0.08, p= 0.001 for Pearson’s,
Mander’s M1 and Mander’s M2), followed by Dunn’s multiple comparison test. WT, Disc1wt/wt; HET, Disc1wt/Der1; HOM and Disc1Der1/Der1. Error bars
represent SEM. ***p < 0.001; **p < 0.01 and *p < 0.05; n indicated on graphs
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number of AMPAR present. On this basis, the Der1
mutant mouse neurons are predicted to possess fewer
synaptic AMPARs and weaker synapses.
AMPAR-induced depolarisation initiates NMDAR-
dependent synaptic plasticity and long-term potentiation
via molecular pathways involving signalling molecules
such as CAMKII, PKA, PDE4 and the transcription factor
CREB48–52. This leads to increased synaptic AMPAR
expression and dendritic spine volume through actin
remodelling, and thus greater synapse strength and
size53,54. Various DISC1 mutant mice exhibit synaptic
plasticity defects34 and in some cases involvement has
been demonstrated of PDE4, which interacts with and is
regulated by DISC125 or CREB34. Moreover, DISC1 is
known to regulate the AMPAR subunit expression and
dendritic spine size/density downstream of NMDA
receptors via actin remodelling11,55, and could therefore
control plasticity through these mechanisms. DISC1 is
also reported to regulate the NMDAR activity through
PDE4-mediated activation of CREB-dependent GluN2A
expression12, although we found no evidence of this
mechanism in Der1 mice since hippocampal GluN2A
levels are unaltered. DISC1 may therefore regulate
synaptic plasticity at multiple levels downstream of
NMDAR, and it is notable that the gene expression
changes in the human neurons derived from t(1;11) car-
riers, including altered expression of PDE4B and genes
required for actin cytoskeleton remodelling, are a good fit
with these processes. Crucially, however, our data indicate
that DISC1 has the potential to modulate the triggering of
plasticity itself, through effects upon synapse strength and
via direct interaction with GluN1, regulation of NMDAR
dynamics and thus control of their synaptic expression
and availability to initiate plasticity. Synaptic plasticity
underlies cognition which is characteristically impaired in
schizophrenia in particular, but also in affective disorders.
Our findings thus point towards a pathway that is of
direct relevance to a core feature of psychiatric disorders
in t(1;11) carriers and to major mental illness in general.
Four potential genetic modifiers have recently been
identified in the t(1;11) family30. Of the genes-of-interest
identified at these loci, only GRM5 and CNTN5 could be
meaningfully examined using the selected panel of t(1;11)
family neurons and although abundantly expressed,
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Fig. 6 Altered PSD95 distribution in Disc1wt/Der1 and Disc1Der1/Der1 hippocampal neurons. a Left, raw 3D-SIM image of a dendrite with PSD95
clusters and nanodomains. Right, the same image with nanodomain centres (bright green spots) identified using Imaris. Scale bar, 1 μm. b PSD95
total volume normalised to dendritic segment volume. Data analysed by Kruskal–Wallis (not significant). c Quantification of single PSD95
nanodomains. Data analysed by one-way ANOVA (p < 0.0001). d Quantification of PSD95 nanodomain number per cluster. Data analysed by two-way
ANOVA which found a significant interaction between genotype and nanodomain number per cluster (p < 0.0001). WT, Disc1wt/wt; HET, Disc1wt/Der1;
HOM and Disc1Der1/Der1. Error bars represent SEM. ***p < 0.001 and **p < 0.01; n indicated on graphs
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neither was found to be dysregulated. Nor were any
deleterious sequence variants that would affect protein
function discovered in these genes30, although potential
expression quantitative trait loci (eQTLs) that could affect
the GRM5 expression levels were previously identified
within the modifier30. Such eQTLs may therefore act
upon GRM5 in a cell type-specific manner. The Der1
mouse mimics disruption of DISC1 by the t(1;11), iso-
lating this event from any effects of the putative modifiers.
We therefore propose that the deleterious effects of
DISC1 disruption upon excitatory synapses, identified
here using the Der1 mutant mouse, contribute sub-
stantially to risk of major mental illness in t(1;11) carriers,
but can be influenced by the genetic modifiers and/or
environmental factors, leading to differing outcomes. This
is consistent with a previous observation that, irrespective
of diagnosis, all tested t(1;11) carriers exhibit an abnormal
schizophrenia endophenotype, the P300 event-related
potential6, and that P300 abnormalities are linked to
NMDAR dysfunction56.
In conclusion, the Der1 mutation-induced NMDAR
trafficking and synapse abnormalities described here
converge upon themes of dysfunctional NMDAR, exci-
tatory synapses and plasticity that are emerging from
schizophrenia and depression GWAS and CNV data. The
t(1;11) thus provides a mechanistic window into the bio-
chemical basis of these disorders, which links to genetic
findings and highlights new ways to consider therapeutic
intervention.
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